Role of immune checkpoint blockers in patients with
EGFR
mutation
Transl Lung Cancer Res
.
2018 Dec;7(Suppl 4):S385-S387.
doi: 10.21037/tlcr.2018.09.13.
Authors
Jeffrey Ward
1
,
Daniel Morgensztern
1
Affiliation
1
Division of Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA.
PMID:
30705863
PMCID:
PMC6328686
DOI:
10.21037/tlcr.2018.09.13
No abstract available
Publication types
Editorial
Comment
Grants and funding
K12 CA167540/CA/NCI NIH HHS/United States